iMDx Prepares for U.S. Commercial Launch of GraftAssureDx as Clinical Trial Nears Completion

GraftAssure™ technology adoption further broadens with 20 global transplant centers engaged by year-end 2025, including first ...

Insight Molecular Diagnostics Inc.: iMDx Prepares for U.S. Commercial Launch of GraftAssureDx as Clinical Trial Nears Completion

GraftAssure technology adoption further broadens with 20 global transplant centers engaged by year-end 2025, including first Canadian siteGraftAssureDx FDA IVD approval application 95% complete at yea ...
Informationsdienst Wissenschaft

PhenoTruck®: Mobile Lab for Early Detection of Plant Pests and Pathogens in Fruit Farming and Viticulture

Pests that spread as a result of climate change pose an increasing threat to fruit farming and viticulture in Germany. Fraunhofer researchers are working with partners to develop methods for the early ...
BioTechniques

What can non-coding DNA tell us about Alzheimer’s disease?

Researchers are investigating the role of non-coding DNA, or junk DNA, in regulating astrocytes, brain cells involved in ...

Genomics in Cancer Care Market Size to Hit USD 69.16 Billion by 2032, Growing at a CAGR of 16.04% - SNS Insider

Advancements in next-generation sequencing technologies, increasing adoption of precision oncology, and rising cancer incidence worldwide are driving the genomics in cancer care market growth.Austin, ...